Agilent Technologies and Ameritox Form Collaboration
News Feb 12, 2013
“By using multiple RapidFire systems Ameritox is streamlining the analysis of small panels of exogenous compounds compared to traditional methods of analysis,” said Can Ozbal, director of Agilent’s RapidFire business.
While Agilent’s RapidFire system has been used extensively in pharmaceutical and biopharmaceutical laboratories, this research collaboration with Ameritox is one of the first for Agilent’s RapidFire team in the field of medication monitoring.
“By working together and sharing moment-by-moment laboratory activity, this research arrangement gives both Ameritox and Agilent a vantage point from which we can continue to discover new uses for our science and technology,” said Jay Zimmerman, chief laboratory officer of Ameritox.
“The marriage of Agilent’s technology and Ameritox’s proprietary science could hold the key to major advancements in the field of medication monitoring,” Zimmerman said.
Key Cancer-Linked Proteins Thought to be ‘Undruggable’ Until NowNews
A new study published in Nature, conducted by an alliance between industry and academia involving the University of Liverpool, highlights a new approach to targeting key cancer-linked proteins, thought to be ‘undruggable’.READ MORE
Scientists Develop a Synthetic Solution to Combat Dwindling Supply of Cancer and HIV DrugNews
Supplies of a promising drug for cancer, HIV and possibly other diseases is dwindling, and scientists have struggled to extract more from the marine creatures who produce it. Now, chemists have a synthetic solution.READ MORE